Biomarin Pharmaceutical Inc (BMRN) — Cash Flow Quality Index
Biomarin Pharmaceutical Inc (BMRN) has a Cash Flow Quality Index of 2.09x as of March 2026. Operating cash flow of $220.65 Million exceeds net income of $105.53 Million, indicating high earnings quality where cash backs reported profits. Explore Biomarin Pharmaceutical Inc (BMRN) cash flow conversion to assess how effectively this company generates cash.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Biomarin Pharmaceutical Inc Cash Flow Quality Index (2008–2025)
Historical Cash Flow Quality Index for Biomarin Pharmaceutical Inc across 7 annual periods. Values consistently above 1.0x indicate high-quality earnings. Check BMRN capex plus investments ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Cash Flow Quality Index for Biomarin Pharmaceutical Inc (2008–2025)
Year-by-year earnings quality comparison for Biomarin Pharmaceutical Inc. For live market cap and the full company financial profile, see Biomarin Pharmaceutical Inc stock valuation.
| Year | Quality Index | Operating CF (USD) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 2.37x | $827.99 Million | $348.90 Million | ▲ +76.8% |
| 2024 | 1.34x | $572.84 Million | $426.86 Million | ▲ +41.3% |
| 2023 | 0.95x | $159.26 Million | $167.65 Million | ▼ -23.5% |
| 2022 | 1.24x | $175.90 Million | $141.56 Million | ▲ +1150.5% |
| 2020 | 0.10x | $85.36 Million | $859.10 Million | ▲ +9.1% |
| 2010 | 0.09x | $18.75 Million | $205.82 Million | ▲ +130.6% |
| 2008 | -0.30x | $-9.18 Million | $30.83 Million | — |